What Management needs to do RIGHT NOW and what they need to stop doing RIGHT NOW!
What we await is news about how they are working with the FDA to help set the new standard for CBD products and an update on our CBD Initiative. If management has any business sense whatsoever, they should have taken the initiative to contact the FDA about their CBD Initiative and see how their approach stacks up to what the FDA wants. The goal would be to align themselves to what the FDA seeks for CBD products. It is critical to start a relationship with the FDA to align themselves to their objectives for CBD in order to get a green light from them that would put NRTI above all the other CBD companies. It would also attract much attention from investors and outside interest that is desperately needed at this point. All this would bolster their position with Nulief and prepare them for a national roll out.
It would also be very wise to develop a plan for securing enough funds to launch Nulief, while conserving some of the funds used to promote their other brands. They could continue with a limited budget for promoting Bikini Ready and still grow the brand, but nothing is more important than preparing for a REAL LAUNCH for Nulief. Getting ahead of everyone else by taking the initiative to develop a working relationship with the FDA now will lead to much greater success for Nulief and their CBD Initiative later on. The FDA moves at a snails pace to approve anything, thus the reason to start NOW!
Some may say "Put a fork in it", but they obviously haven't done any DD to see the huge opportunity that still exist for NRTI with their CBD Initiative. We have the manufacturing process and retail infrastructure already in place, with huge support and endorsements from their Advisory board to make their CBD a huge success. The icing on the cake would be the nod from the FDA on their Nulief CBD product. We have the distinct possibility of becoming the first CBD company to receive FDA support, which would send the share price rocketing upward. This is why Kras should be thinking this through and taking a proactive approach with the FDA right now.
I have also worked in the pharmaceutical division for P&G for 10+ years, until they sold their pharmaceutical division to Warner Chilcott, so I do have some extensive experience in this area, as well as on the retail side. I have learned what works and what doesn't, as well as many tricks of the trade to give one the best shot for success and one of them is to develop a relationship with the FDA early on to get leg up on the competition. Which is why I suggest NRTI does the same right now to get ahead of the game.
The way I see it, this is a do or die situation for NRTI, whereas, if they take the proper steps to get Nulief to retail ahead of competition and keep us informed about their CBD Initiative along the way, we will come back with a flurry, but if we are kept in the dark and the company concentrates more on their other brands instead of their CBD Initiative, we are dead in the water! In a nutshell, that is what it all boils down to and why it is imperative that Kras work with the FDA now and give shareholders a complete update on their CBD Initiative. That is what the market is screaming for and needs, so why not give the market what it wants? If you do the share price goes up, but if not and you continue to ram the other brands down our throats with continual PR's, the share price will languish and eventually keep going lower and lower.
Wait and bundle the news for a whole quarter on all the other brands like Bikini Ready, Slim Trim, Surgex, etc., which will not only save money, but also stop hurting the share price. That should be extremely evident by now and when something isn't working you analyze the situation and make a change! That is what GREAT MANAGEMENT does, they change what isn't working and they sure as hell don't keep doing what isn't working! It is also necessary to keep the market apprised of what is going on with they are most interested in, which is your CBD Initiative. DO THAT AND OUR SHARE PRICE WILL CONTINUE TO RISE, DON'T AND THE SHARE PRICE WILL SUFFER!
If management can get that and act accordingly, we are in for an exciting rest of the year. I mean come on it that hard to do and it only make sense if you want the company to succeed and build shareholder value! Let's see which approach they take! Cheers!
What we await is news about how they are working with the FDA to help set the new standard for CBD products and an update on our CBD Initiative. If management has any business sense whatsoever, they should have taken the initiative to contact the FDA about their CBD Initiative and see how their approach stacks up to what the FDA wants. The goal would be to align themselves to what the FDA seeks for CBD products. It is critical to start a relationship with the FDA to align themselves to their objectives for CBD in order to get a green light from them that would put NRTI above all the other CBD companies. It would also attract much attention from investors and outside interest that is desperately needed at this point. All this would bolster their position with Nulief and prepare them for a national roll out.
It would also be very wise to develop a plan for securing enough funds to launch Nulief, while conserving some of the funds used to promote their other brands. They could continue with a limited budget for promoting Bikini Ready and still grow the brand, but nothing is more important than preparing for a REAL LAUNCH for Nulief. Getting ahead of everyone else by taking the initiative to develop a working relationship with the FDA now will lead to much greater success for Nulief and their CBD Initiative later on. The FDA moves at a snails pace to approve anything, thus the reason to start NOW!
Some may say "Put a fork in it", but they obviously haven't done any DD to see the huge opportunity that still exist for NRTI with their CBD Initiative. We have the manufacturing process and retail infrastructure already in place, with huge support and endorsements from their Advisory board to make their CBD a huge success. The icing on the cake would be the nod from the FDA on their Nulief CBD product. We have the distinct possibility of becoming the first CBD company to receive FDA support, which would send the share price rocketing upward. This is why Kras should be thinking this through and taking a proactive approach with the FDA right now.
I have also worked in the pharmaceutical division for P&G for 10+ years, until they sold their pharmaceutical division to Warner Chilcott, so I do have some extensive experience in this area, as well as on the retail side. I have learned what works and what doesn't, as well as many tricks of the trade to give one the best shot for success and one of them is to develop a relationship with the FDA early on to get leg up on the competition. Which is why I suggest NRTI does the same right now to get ahead of the game.
The way I see it, this is a do or die situation for NRTI, whereas, if they take the proper steps to get Nulief to retail ahead of competition and keep us informed about their CBD Initiative along the way, we will come back with a flurry, but if we are kept in the dark and the company concentrates more on their other brands instead of their CBD Initiative, we are dead in the water! In a nutshell, that is what it all boils down to and why it is imperative that Kras work with the FDA now and give shareholders a complete update on their CBD Initiative. That is what the market is screaming for and needs, so why not give the market what it wants? If you do the share price goes up, but if not and you continue to ram the other brands down our throats with continual PR's, the share price will languish and eventually keep going lower and lower.
Wait and bundle the news for a whole quarter on all the other brands like Bikini Ready, Slim Trim, Surgex, etc., which will not only save money, but also stop hurting the share price. That should be extremely evident by now and when something isn't working you analyze the situation and make a change! That is what GREAT MANAGEMENT does, they change what isn't working and they sure as hell don't keep doing what isn't working! It is also necessary to keep the market apprised of what is going on with they are most interested in, which is your CBD Initiative. DO THAT AND OUR SHARE PRICE WILL CONTINUE TO RISE, DON'T AND THE SHARE PRICE WILL SUFFER!
If management can get that and act accordingly, we are in for an exciting rest of the year. I mean come on it that hard to do and it only make sense if you want the company to succeed and build shareholder value! Let's see which approach they take! Cheers!
